Lucinfig

Lucinfig uses and dosage

Lucinfig (Infigratinib), generic Truseltiq is a prescription medicine used to treat adults with previously treated, unresectable locally advanced or metastatic cholangiocarcinoma whose tumors harbor a fibroblast growth factor receptor 2 (FGFR2) fusion or other rearrangement, as confirmed by an FDA-approved diagnostic test. Lucinfig manufactured by Lucius Pharma Ltd. In Laos. Infigratinib has to take orally once daily for 21 days after meals, followed by 7 days off therapy.

Lucinfig side effects

The most common side effects of Infigratinib are: Headache, Abdominal pain, Nausea, Abdominal distension, Dizziness.

Originator brand

Truseltiq by QED Therapeutics, Inc

Made by

Lucius Pharma

This information is provided for reference only and is not medical advice. Always consult a qualified healthcare professional.